{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:39:42Z","timestamp":1768505982607,"version":"3.49.0"},"posted":{"date-parts":[[2023,7,1]]},"group-title":"Cancer Biology","reference-count":51,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Nucleotide excision repair (NER) neutralizes treatment with platinum (Pt)-based chemotherapy by removing Pt lesions from DNA. Previous study has identified that missense mutation or loss of either of the NER genes Excision Repair Cross Complementation Group 1 and 2 (\n                  <jats:italic>ERCC1<\/jats:italic>\n                  and\n                  <jats:italic>ERCC2<\/jats:italic>\n                  ) leads to improved patient outcomes after treatment with Pt-based chemotherapies. Although most NER gene alterations found in patient tumors are missense mutations, the impact of such mutations in the remaining nearly 20 NER genes is unknown. Towards this goal, we previously developed a machine learning strategy to predict genetic variants in an essential NER scaffold protein, Xeroderma Pigmentosum Complementation Group A (XPA), that disrupt repair activity on a UV-damaged substrate. In this study, we report in-depth analyses of a subset of the predicted NER-deficient XPA variants, including\n                  <jats:italic>in vitro<\/jats:italic>\n                  analyses of purified recombinant protein and cell-based assays to test Pt agent sensitivity in cells and determine mechanisms of NER dysfunction. The most NER deficient variant Y148D had reduced protein stability, weaker DNA binding, disrupted recruitment to damage, and degradation resulting from tumor missense mutation. Our findings demonstrate that tumor mutations in XPA impact cell survival after cisplatin treatment and provide valuable mechanistic insights to further improve variant effect prediction efforts. More broadly, these findings suggest XPA tumor variants should be considered when predicting patient response to Pt-based chemotherapy.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>Significance<\/jats:title>\n                  <jats:p>A destabilized, readily degraded tumor variant identified in the NER scaffold protein XPA sensitizes cells to cisplatin, suggesting that XPA variants can be used to predict response to chemotherapy.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2023.06.29.547124","type":"posted-content","created":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T03:35:20Z","timestamp":1688268920000},"source":"Crossref","is-referenced-by-count":0,"title":["XPA tumor variants lead to defects in NER that sensitize cells to cisplatin"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4959-5466","authenticated-orcid":false,"given":"Alexandra M.","family":"Blee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlyn S.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina R.","family":"Troll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areetha","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Drew","family":"Neufer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orlando D.","family":"Sch\u00e4rer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter J.","family":"Chazin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2023070603350602000_2023.06.29.547124v1.1","doi-asserted-by":"publisher","DOI":"10.1021\/cr040483f"},{"key":"2023070603350602000_2023.06.29.547124v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3822"},{"key":"2023070603350602000_2023.06.29.547124v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2003.09.010"},{"key":"2023070603350602000_2023.06.29.547124v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2006.12.020"},{"key":"2023070603350602000_2023.06.29.547124v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2010.03.010"},{"key":"2023070603350602000_2023.06.29.547124v1.6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1158\/1078-0432.CCR-18-1001","article-title":"ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer","volume":"25","year":"2019","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"2023070603350602000_2023.06.29.547124v1.7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1001\/jamaoncol.2016.1056","article-title":"Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma","volume":"2","year":"2016","journal-title":"JAMA Oncol"},{"key":"2023070603350602000_2023.06.29.547124v1.8","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0623"},{"key":"2023070603350602000_2023.06.29.547124v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.03.076"},{"key":"2023070603350602000_2023.06.29.547124v1.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2817-4"},{"key":"2023070603350602000_2023.06.29.547124v1.11","doi-asserted-by":"crossref","unstructured":"Blee AM , Li B , Pecen T , Meiler J , Nagel ZD , Capra JA , et al. An active learning framework improves tumor variant interpretation. Cancer research 2022","DOI":"10.1101\/2021.11.08.467747"},{"key":"2023070603350602000_2023.06.29.547124v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1218(74)90015-9"},{"key":"2023070603350602000_2023.06.29.547124v1.13","doi-asserted-by":"crossref","first-page":"e2207408119","DOI":"10.1073\/pnas.2207408119","article-title":"Two interaction surfaces between XPA and RPA organize the preincision complex in nucleotide excision repair","volume":"119","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"2023070603350602000_2023.06.29.547124v1.14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz629"},{"key":"2023070603350602000_2023.06.29.547124v1.15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M213155200"},{"key":"2023070603350602000_2023.06.29.547124v1.16","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/21.8.2045"},{"key":"2023070603350602000_2023.06.29.547124v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/bs.mie.2017.03.008"},{"key":"2023070603350602000_2023.06.29.547124v1.18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.9.e45"},{"key":"2023070603350602000_2023.06.29.547124v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2006.339"},{"key":"2023070603350602000_2023.06.29.547124v1.20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.067538"},{"key":"2023070603350602000_2023.06.29.547124v1.21","doi-asserted-by":"crossref","unstructured":"Rafehi H , Orlowski C , Georgiadis GT , Ververis K , El-Osta A , Karagiannis TC . Clonogenic assay: adherent cells. J Vis Exp 2011","DOI":"10.3791\/2573"},{"key":"2023070603350602000_2023.06.29.547124v1.22","doi-asserted-by":"crossref","unstructured":"Orellana EA , Kasinski AL . Sulforhodamine B (SRB) Assay in Cell Culture to Investigate Cell Proliferation. Bio Protoc 2016;6","DOI":"10.21769\/BioProtoc.1984"},{"key":"2023070603350602000_2023.06.29.547124v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2006.179"},{"key":"2023070603350602000_2023.06.29.547124v1.24","first-page":"39","article-title":"Sulforhodamine B assay and chemosensitivity","volume":"110","year":"2005","journal-title":"Methods Mol Med"},{"key":"2023070603350602000_2023.06.29.547124v1.25","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1021\/acs.biochem.0c00441","article-title":"Remarkable Enhancement of Nucleotide Excision Repair of a Bulky Guanine Lesion in a Covalently Closed Circular DNA Plasmid Relative to the Same Linearized Plasmid","volume":"59","year":"2020","journal-title":"Biochemistry"},{"key":"2023070603350602000_2023.06.29.547124v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2006.202"},{"key":"2023070603350602000_2023.06.29.547124v1.27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/bs.mie.2017.07.002","article-title":"A Polymerase With Potential: The Fe-S Cluster in Human DNA Primase","volume":"595","year":"2017","journal-title":"Methods Enzymol"},{"key":"2023070603350602000_2023.06.29.547124v1.28","doi-asserted-by":"crossref","unstructured":"Salay LE , Blee AM , Raza MK , Gallagher KS , Chen H , Dorfeuille AJ , et al. Modification of the 4Fe-4S Cluster Charge Transport Pathway Alters RNA Synthesis by Yeast DNA Primase. Biochemistry 2022","DOI":"10.1021\/acs.biochem.2c00100"},{"key":"2023070603350602000_2023.06.29.547124v1.29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz1231"},{"key":"2023070603350602000_2023.06.29.547124v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)00281-7"},{"key":"2023070603350602000_2023.06.29.547124v1.31","doi-asserted-by":"publisher","DOI":"10.1021\/bi991755p"},{"key":"2023070603350602000_2023.06.29.547124v1.32","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/26.11.2779"},{"key":"2023070603350602000_2023.06.29.547124v1.33","doi-asserted-by":"publisher","DOI":"10.1038\/1400"},{"key":"2023070603350602000_2023.06.29.547124v1.34","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.bbrc.2019.05.050","article-title":"Structural characterization of the redefined DNA-binding domain of human XPA","volume":"514","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"2023070603350602000_2023.06.29.547124v1.35","doi-asserted-by":"publisher","DOI":"10.1002\/med.1009"},{"key":"2023070603350602000_2023.06.29.547124v1.36","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s12272-020-01281-8","article-title":"Ubiquitin-proteasome system (UPS) as a target for anticancer treatment","volume":"43","year":"2020","journal-title":"Arch Pharm Res"},{"key":"2023070603350602000_2023.06.29.547124v1.37","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth0410-248"},{"key":"2023070603350602000_2023.06.29.547124v1.38","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(98)00029-8"},{"key":"2023070603350602000_2023.06.29.547124v1.39","doi-asserted-by":"crossref","first-page":"e478s","DOI":"10.6061\/clinics\/2018\/e478s","article-title":"DNA repair pathways and cisplatin resistance: an intimate relationship","volume":"73","year":"2018","journal-title":"Clinics (Sao Paulo"},{"key":"2023070603350602000_2023.06.29.547124v1.40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.22.10394"},{"key":"2023070603350602000_2023.06.29.547124v1.41","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/25.3.480"},{"key":"2023070603350602000_2023.06.29.547124v1.42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.12.7177"},{"key":"2023070603350602000_2023.06.29.547124v1.43","doi-asserted-by":"publisher","DOI":"10.1021\/bi960453+"},{"key":"2023070603350602000_2023.06.29.547124v1.44","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.10.5396"},{"key":"2023070603350602000_2023.06.29.547124v1.45","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ijbiomac.2020.01.169","article-title":"New structural insights into the recognition of undamaged splayed-arm DNA with a single pair of non-complementary nucleotides by human nucleotide excision repair protein XPA","volume":"148","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"2023070603350602000_2023.06.29.547124v1.46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1107\/S2053230X18016990","article-title":"The redefined DNA-binding domain of human xeroderma pigmentosum complementation group A: production, crystallization and structure solution","volume":"75","year":"2019","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"2023070603350602000_2023.06.29.547124v1.47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.800078"},{"key":"2023070603350602000_2023.06.29.547124v1.48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/BST20210246","article-title":"Mechanism of action of nucleotide excision repair machinery","volume":"50","year":"2022","journal-title":"Biochem Soc Trans"},{"key":"2023070603350602000_2023.06.29.547124v1.49","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012609"},{"key":"2023070603350602000_2023.06.29.547124v1.50","doi-asserted-by":"crossref","first-page":"e1006842","DOI":"10.1371\/journal.pgen.1006842","article-title":"Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?","volume":"13","year":"2017","journal-title":"PLoS Genet"},{"key":"2023070603350602000_2023.06.29.547124v1.51","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00308-y"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.06.29.547124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:51:52Z","timestamp":1768452712000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2023.06.29.547124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1101\/2023.06.29.547124","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1093\/narcan\/zcae013","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,7,1]]},"subtype":"preprint"}}